Pablo
Vidal Cortes
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (11)
2023
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
2022
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
-
Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections
Medicina Intensiva, Vol. 46, Núm. 9, pp. 508-520
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Annals of Intensive Care, Vol. 11, Núm. 1
-
Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)
Medicina Intensiva, Vol. 45, Núm. 2, pp. 104-121
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2020
-
Update of the treatment of nosocomial pneumonia in the ICU
Critical Care, Vol. 24, Núm. 1